About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Zydus Healthcare Arm Acquires Six Drugs from United States Drug Maker MSD

by Dr. Trupti Shirole on December 29, 2016 at 12:35 PM
Font : A-A+

 Zydus Healthcare Arm Acquires Six Drugs from United States Drug Maker MSD

In a strategic acquisition, Pharma major Zydus Cadila announced that its healthcare arm had acquired six brands from United States drug maker MSD and its subsidiaries for an undisclosed amount.

The Mumbai-based MSD is the Indian subsidiary of the American global pharmaceutical multinational Merck & Co, which is Merck Sharp & Dohme (MSD) outside the US and Canada.

Advertisement


The brands are Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten in the men's health, women's health, wound management and cardiovascular therapy segments.

"The deal includes transfer of distribution and commercial rights and assignment of trademarks of the six brands to Zydus Healthcare Ltd in India," said the city-based company in a statement here.
Advertisement

MSD's other Indian arm - Organon Ltd also transferred the distribution and commercial rights for Deca-Durabolin and Durabolin to Zydus for Nepal.

"MSD's brands are a perfect addition and complement our core business with their strong equity. We look at this as an opportunity to strengthen our offerings to create value and growth," said Zydus Healthcare Chairman Sharvil Patel.

The acquisition will strengthen Zydus' portfolio in therapeutic segments, as Deca-Durabolin and Durabolin are prescribed drugs for treating osteoporosis, muscle wasting and management of negative nitrogen balance.

Sustanon is an injectable testosterone replacement therapy for men, while Multiload is an intra uterine device or contraceptive for women.

Axeten is an anti-hypertensive drug and Sicastat is used for healing wounds.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Awareness about Healthcare Insurance in India Healthcare Insurance-Common Terms and Definitions Drugs Banned in India 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) The Essence of Yoga Turmeric Powder - Health Benefits, Uses & Side Effects Indian Medical Journals Blood Pressure Calculator Find a Doctor Color Blindness Calculator Sinopril (2mg) (Lacidipine) Pregnancy Confirmation Calculator Blood - Sugar Chart
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Zydus Healthcare Arm Acquires Six Drugs from United States Drug Maker MSD Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests